"Thymus Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the THYMUS GLAND.
- Thymus Neoplasms
- Neoplasm, Thymus
- Thymus Neoplasm
- Thymus Tumors
- Thymus Tumor
- Tumor, Thymus
- Tumors, Thymus
- Thymic Neoplasms
- Thymic Tumors
- Thymic Tumor
- Tumor, Thymic
- Tumors, Thymic
- Neoplasms, Thymic
- Neoplasm, Thymic
- Thymic Neoplasm
- Neoplasms, Thymus
Cancer of Thymus
- Cancer of Thymus
- Thymus Cancers
- Thymic Cancer
- Cancer, Thymic
- Cancers, Thymic
- Thymic Cancers
- Thymus Cancer
- Cancer, Thymus
- Cancers, Thymus
- Cancer of the Thymus
Below are MeSH descriptors whose meaning is more general than "Thymus Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Thymus Neoplasms".
This graph shows the total number of publications written about "Thymus Neoplasms" by people in this website by year, and whether "Thymus Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Thymus Neoplasms" by people in Profiles.
Sachidananda S, Denlinger CE. Commentary: Thymic epithelial tumors-time to move beyond traditional staging? J Thorac Cardiovasc Surg. 2021 07; 162(1):318-319.
Jackson MW, Palma DA, Camidge DR, Jones BL, Robin TP, Sher DJ, Koshy M, Kavanagh BD, Gaspar LE, Rusthoven CG. The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma. J Thorac Oncol. 2017 04; 12(4):734-744.
Turton JA, Sones WR, Andrews CM, Pilling AM, Williams TC, Molyneux G, Rizzo S, Gordon-Smith EC, Gibson FM. Further development of a model of chronic bone marrow aplasia in the busulphan-treated mouse. Int J Exp Pathol. 2006 Feb; 87(1):49-63.
Nguyen CL, Salem ML, Rubinstein MP, Demcheva M, Vournakis JN, Cole DJ, Gillanders WE. Mechanisms of enhanced antigen-specific T cell response following vaccination with a novel peptide-based cancer vaccine and systemic interleukin-2 (IL-2). Vaccine. 2003 Jun 02; 21(19-20):2318-28.
Maitre N, Brown JM, Demcheva M, Kelley JR, Lockett MA, Vournakis J, Cole DJ. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination. Clin Cancer Res. 1999 May; 5(5):1173-82.
Skeie GO, Pandey JP, Aarli JA, Gilhus NE. TNFA and TNFB polymorphisms in myasthenia gravis. Arch Neurol. 1999 Apr; 56(4):457-61.
Kulling D, Reed CE, Verne GN, Cotton PB, Tarnasky PR. Intestinal pseudo-obstruction as a paraneoplastic manifestation of malignant thymoma. Am J Gastroenterol. 1997 Sep; 92(9):1564-6.
Skeie GO, Pandey JP, Aarli JA, Gilhus NE. Autoimmunity to ryanodine receptor and titin in myasthenia gravis is associated with GM allotypes. Autoimmunity. 1997; 26(2):111-6.
Gilhus NE, Pandey JP, Gaarder PI, Aarli JA. Immunoglobulin allotypes in myasthenia gravis patients with a thymoma. J Autoimmun. 1990 Jun; 3(3):299-305.
Nagarkatti M, Nagarkatti PS, Kaplan AM. Differential effects of BCNU on T cell, macrophage, natural killer and lymphokine-activated killer cell activities in mice bearing a syngeneic tumor. Cancer Immunol Immunother. 1988; 27(1):38-46.